Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup
This book review appraises John Carreyrou’s non-fiction book Bad Blood. The text provides penetrating insights on Theranos, an American laboratory diagnostics company that promised to revolutionize laboratory medicine. The author’s award-winning prose relays the events leading to the eventual disco...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Ottawa
2019-05-01
|
Series: | University of Ottawa Journal of Medicine |
Subjects: | |
Online Access: | https://uottawa.scholarsportal.info/ottawa/index.php/uojm-jmuo/article/view/4159 |
id |
doaj-7950ce8e145f4995b174ecbc9b57bad4 |
---|---|
record_format |
Article |
spelling |
doaj-7950ce8e145f4995b174ecbc9b57bad42020-11-24T21:16:54ZengUniversity of OttawaUniversity of Ottawa Journal of Medicine2292-650X2292-65182019-05-019110.18192/uojm.v9i1.4159Book Review: Bad Blood – Secrets and Lies in a Silicon Valley StartupEmeril Santander0University of Ottawa This book review appraises John Carreyrou’s non-fiction book Bad Blood. The text provides penetrating insights on Theranos, an American laboratory diagnostics company that promised to revolutionize laboratory medicine. The author’s award-winning prose relays the events leading to the eventual discovery of fraud at Theranos as well as the subsequent collapse of the company. The book can be faulted for being unripe. Publication prior to a full resolution to the Theranos affair precludes analysis of the longer-term impacts of this fraud. Notwithstanding Bad Blood’s imperfect timing, the book remains a seminal text amidst journalistic chronicles of medical innovation gone wrong. https://uottawa.scholarsportal.info/ottawa/index.php/uojm-jmuo/article/view/4159fraudTheranosCarreyrouinnovationmedicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Emeril Santander |
spellingShingle |
Emeril Santander Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup University of Ottawa Journal of Medicine fraud Theranos Carreyrou innovation medicine |
author_facet |
Emeril Santander |
author_sort |
Emeril Santander |
title |
Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup |
title_short |
Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup |
title_full |
Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup |
title_fullStr |
Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup |
title_full_unstemmed |
Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup |
title_sort |
book review: bad blood – secrets and lies in a silicon valley startup |
publisher |
University of Ottawa |
series |
University of Ottawa Journal of Medicine |
issn |
2292-650X 2292-6518 |
publishDate |
2019-05-01 |
description |
This book review appraises John Carreyrou’s non-fiction book Bad Blood. The text provides penetrating insights on Theranos, an American laboratory diagnostics company that promised to revolutionize laboratory medicine. The author’s award-winning prose relays the events leading to the eventual discovery of fraud at Theranos as well as the subsequent collapse of the company. The book can be faulted for being unripe. Publication prior to a full resolution to the Theranos affair precludes analysis of the longer-term impacts of this fraud. Notwithstanding Bad Blood’s imperfect timing, the book remains a seminal text amidst journalistic chronicles of medical innovation gone wrong.
|
topic |
fraud Theranos Carreyrou innovation medicine |
url |
https://uottawa.scholarsportal.info/ottawa/index.php/uojm-jmuo/article/view/4159 |
work_keys_str_mv |
AT emerilsantander bookreviewbadbloodsecretsandliesinasiliconvalleystartup |
_version_ |
1726015228720709632 |